Brambles Limited (BXBLY) Fair Value & Analysis
Industrials · US · Market cap $17.7B
Brambles Limited
BXBLY · US
Fair value as of: Jun 24, 2026
From 25 valuation models · updated 11 days ago
Fair value updated Jun 24, 2026 — revised from $23.98 to $24.68 (+2.9%) since Jun 23, 2026. Share price +13.4% over the past month.
Price vs Fair Value (12 months)
12‑month range $22.43 – $34.05 · fair‑value band $15.56 – $35.09 · the $26.11 price screens above the $24.68 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Brambles Limited (BXBLY) currently trades at $26.11, while our model-based Fair Value estimate is $24.68 — implying the stock looks roughly 5.5% overvalued today. We read business quality at 57/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Brambles Limited generated revenue of $7.0B at a net margin of 13.7%. Revenue grew 5.0% year over year. It earns a return on equity of 28.1%. Net debt stands at $2.6B. Fundamentals as of Jun 24, 2026
Our scenario range runs from $15.56 (bear case) to $35.09 (bull case); at $26.11, the current price sits within that range. The share trades about 26% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -31% fair-value upside — at -5%, BXBLY screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Brambles Limited operates as a supply-chain logistics company. It operates through CHEP Americas, CHEP EMEA, and CHEP Asia-Pacific segments. The company offers platforms to transport goods across their supply chains. Its products include reusable pallets and containers. The company serves consumer staples, retail, automotive, and general manufacturing industries. Brambles Limited was founded in 1875 and is based in Sydney, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Brambles Limited reported revenue of $6.8B in FY2025 versus $5.2B in FY2021, a compound +6.9%/yr. Reported net income was $896M in FY2025, compounding +14.2%/yr from FY2021.
Is BXBLY fairly valued? → Check now
Recent news
- New Strong Sell Stocks for June 29th
- With EPS Growth And More, Brambles (ASX:BXB) Makes An Interesting Case
- Brambles Lowers Full-year Guidance; Announces $400 Mln Share Buyback
- Brambles Earns No. 2 Industry Ranking in Dow Jones Best-in-Class World Index
External third-party headlines (Yahoo Finance, Reuters and others) — not an editorial selection, not financial advice.
Similar stocks
10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Cintas Corporation CTAS | $169.45 | $82.75 | -51% |
| RELX PLC R1EL34 | R$45.28 | R$23.22 | -49% |
| Thomson Reuters Corporation TRI | C$114.51 | C$85.90 | -25% |
| Copart, Inc CPRT | $30.77 | $28.89 | -6% |
| Global Payments Inc GPN | $65.09 | $70.80 | +9% |
| UL Solutions Inc ULS | $97.38 | $29.61 | -70% |
| RB Global, Inc RBA | $104.49 | $46.94 | -55% |
| Wolters Kluwer N.V WOSB | €61.14 | €57.13 | -7% |
| Rentokil Initial plc RTO | $28.35 | $19.63 | -31% |
| Aramark ARMK | $53.34 | $11.37 | -79% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Brambles Limited (BXBLY) undervalued?
What is the fair value of BXBLY?
What is the quality score of BXBLY?
What is the revenue of Brambles Limited (BXBLY)?
What is the net profit margin of BXBLY?
Does Brambles Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.